![]() |
市场调查报告书
商品编码
1662787
2030 年管瓶盒市场预测:按产品、材料、设计、应用、最终用户和地区进行的全球分析Vial Box Market Forecasts to 2030 - Global Analysis By Product (Single Vial Boxes, Multi-Vial Boxes, Specialty Vial Boxes and Other Products), Material, Design, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球管瓶盒市值为 25.2 亿美元,预计到 2030 年将达到 47.3 亿美元,预测期内的复合年增长率为 7.8%。
管瓶盒是一种用于储存和保护管瓶(通常用于储存液体或药物的小瓶子)的容器。这些盒子通常由纸板、塑胶或木材等耐用材料製成,旨在让管瓶井然有序且安全。管瓶盒通常用于医疗领域,以安全储存和运输物质。它们可能还具有隔间或缓衝垫,以防止破损或污染并确保管瓶内部的完整性。
美国国家癌症实验室报告称,2020年诊断出约180万例新癌症病例,推动了Pemetrexed100毫克/管瓶、500毫克/管瓶、1000毫克/管瓶和单剂量注射管瓶的销量增长。
结构化包装的需求不断增加
纸巾型包装的需求日益增长,在满足药品高效储存、运输和保护需求方面发挥关键作用。随着医疗保健和製药业的扩张,特别是生技药品、疫苗和药品的增加,结构化包装可确保精密管瓶的安全处理。管瓶盒提供结构化的存储,并防止破损、污染和混淆,这对于保持产品完整性至关重要。此外,它还支援高效的库存管理、易于存取和法规遵循,从而加速市场需求。
原物料价格波动
管瓶盒市场原料价格的波动源自于供应链中断、地缘政治紧张局势及包装材料需求变化等因素。由于全球市场变化、燃料成本和生产限制,纸板、塑胶和其他包装部件等主要材料的价格会出现波动。这种变化可能会导緻管瓶盒製造商的生产成本更高。结果,更高的成本可能会转嫁给消费者,限制其承受能力并阻碍市场成长。
扩大网路药品销售
随着电子商务平台的发展,对于运输药品、疫苗和其他健康相关产品的安全、可靠且井然有序的包装的需求日益增加。管瓶盒,尤其是专为温度敏感物品设计的小瓶盒,可在运输过程中提供安全的解决方案。随着消费者越来越多地在线机会药品,公司需要能够确保产品完整性、法规遵从性并防止运输过程中损坏的包装,这导致市场对高品质管瓶盒的需求不断增长。
来自替代包装解决方案的竞争
管瓶盒的替代包装解决方案包括塑胶容器、玻璃瓶、泡壳包装和软袋。这些选项可能具有成本更低、重量更轻、在某些应用领域更为便利等优势。例如,塑胶容器通常比管瓶盒更耐用、更经济,而泡壳包装更节省空间。这些替代品的竞争可能会阻碍管瓶盒市场的成长,因为它们提供更实惠、更实用的解决方案,尤其是在消费者对价格敏感的市场中。
COVID-19 疫情增加了对安全包装解决方案的需求,尤其是对疫苗和药品的需求,从而对管瓶盒市场产生了重大影响。疫苗分发的激增和对温控包装的需求推动了市场的成长。然而,由于供应链中断、原材料短缺和製造成本增加,挑战也随之而来。从正面的一面来看,这场疫情凸显了可靠的管瓶包装在医疗保健中的重要性,为管瓶盒市场的创新和扩张创造了长期机会。
预计储存和组织部门在预测期内将占最大份额
预计预测期内,储存和组织部门将占据最大的市场占有率。管瓶盒透过带有标籤的隔间简化了样品识别,这使其成为有序存放和轻鬆检索的必需品。它确保安全处理,最大限度地减少污染并实现高效的库存管理。这些盒子由塑胶、纸板或聚丙烯製成,通常具有坚固的盖子和隔板,以防止溢出和破损。有些甚至具有极低温度的低温能力。
预计预测期内製药业部门将以最高的复合年增长率成长。
预计预测期内製药业将呈现最高成长率。管瓶盒用于储存、运输和保护装有液体或粉末状药物、疫苗或生物样本的管瓶。确保产品安全、无菌并防止污染、潮湿和物理损坏。它还透过提供适当的标籤、序列化和防篡改功能来帮助您遵守监管标准,确保药品分发安全有效。
预计预测期内亚太地区将占据最大的市场占有率。这是由于对医疗保健和药品的需求不断增长,尤其是在中国和印度等新兴经济体。该地区的药品製造和出口活动正在扩大,对安全的纸巾型管瓶包装解决方案的需求也随之增加。此外,医疗保健投资的增加、政府改善医疗保健基础设施的措施以及慢性病盛行率的上升也促进了市场扩张。
在强劲的製药业和先进的医疗保健基础设施的推动下,北美地区预计在预测期内呈现最高的复合年增长率。对疫苗、生技药品和药品安全包装的需求不断增加,尤其是自 COVID-19 疫情爆发以来,市场规模不断扩大。强而有力的法律规范和对安全和合规的关注进一步推动了市场需求。此外,该地区对永续包装解决方案和环保材料进步的关注正在塑造市场。
According to Stratistics MRC, the Global Vial Box Market is accounted for $2.52 billion in 2024 and is expected to reach $4.73 billion by 2030 growing at a CAGR of 7.8% during the forecast period. A vial box is a container designed to store and protect vials, which are small bottles typically used to hold liquids or pharmaceuticals. These boxes are often made of durable materials such as cardboard, plastic, or wood, and are designed to keep vials organized and secure. Vial boxes are commonly used in the medical field for the safe storage and transport of substances. They may have compartments or cushioning to prevent breakage and contamination, ensuring the integrity of the vials inside.
According to the National Cancer Institute reports in 2020, around 1.8 million new cancer cases were diagnosed in the USA that rose the sales of pemetrexed in 100mg/vial, 500 mg/vial, and 1000 mg/vial, and single-dose vials for injection.
Rising demand for organized packaging
Rising demand for organized packaging plays a crucial role in addressing the need for efficient storage, transportation, and protection of pharmaceutical products. As the healthcare and pharmaceutical sectors expand, particularly with the increase in biologics, vaccines, and medicines, organized packaging ensures the safe handling of delicate vials. Vial boxes provide structured storage, preventing breakage, contamination, and mix-ups, which are essential for maintaining product integrity. Additionally, they support efficient inventory management, ease of access, and regulatory compliance, accelerates the market demand.
Fluctuating raw material prices
Fluctuating raw material prices in the vial box market arise from factors such as supply chain disruptions, geopolitical tensions, and shifts in demand for packaging materials. Key materials like cardboard, plastic, and other packaging components experience price volatility due to changes in global markets, fuel costs, and production limitations. These fluctuations can lead to increased production costs for vial box manufacturers. Consequently, higher costs may be passed on to consumers, limiting affordability and hindering market growth.
Expansion of online pharmaceutical product sales
As e-commerce platforms grow, the demand for secure, reliable, and well-organized packaging for the transportation of medications, vaccines, and other health-related products rises. Vial boxes, especially those designed for temperature-sensitive items, offer a safe solution during transit. With consumers increasingly purchasing pharmaceuticals online, companies need packaging that ensures product integrity, compliance with regulations, and prevents damage during shipping, thus driving the demand for high-quality vial boxes in the market.
Competition from alternative packaging solutions
Alternative packaging solutions to vial boxes include plastic containers, glass bottles, blister packs, and flexible pouches. These options may offer benefits such as lower costs, lighter weight, and convenience in certain applications. For instance, plastic containers are often more durable and cost-effective than vial boxes, while blister packs are more space-efficient. Competition from these alternatives can hamper the vial box market's growth by offering more affordable and practical solutions, especially in markets with price-sensitive consumers.
The covid-19 pandemic significantly impacted the vial box market by increasing demand for secure packaging solutions, particularly for vaccines and pharmaceutical products. The surge in vaccine distribution and the need for temperature-controlled packaging drove the market's growth. However, supply chain disruptions, raw material shortages, and increased production costs posed challenges. On the positive side, the pandemic highlighted the importance of reliable vial packaging for healthcare, creating long-term opportunities for innovation and expansion in the vial box market.
The storage & organization segment is expected to be the largest during the forecast period
The storage & organization segment is expected to account for the largest market share during the forecast period. Vial boxes streamline sample identification with labeled compartments, making them essential for systematic storage and easy retrieval. It ensures safe handling, minimizes contamination, and provides efficient inventory management. These boxes are often made from plastic, cardboard, or polypropylene, with secure lids and dividers to prevent spills or breakage. Some feature cryogenic compatibility for ultra-low temperatures.
The pharmaceutical industry segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the pharmaceutical industry segment is predicted to witness the highest growth rate. A vial box in the pharmaceuticals is designed to store, transport, and protect vials containing liquid or powdered medications, vaccines, or biological samples. It ensures product safety, sterility, and protection from contamination, moisture, and physical damage. They also support compliance with regulatory standards by providing proper labeling, serialization, and tamper-evident features, ensuring secure and efficient pharmaceutical distribution.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to the rising demand for healthcare and pharmaceutical products, especially in emerging economies like China and India. The region's growing pharmaceutical manufacturing and export activities have fuelled the need for secure and organized vial packaging solutions. Additionally, increasing healthcare investments, government initiatives to improve medical infrastructure, and the growing prevalence of chronic diseases contribute to market expansion.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by the robust pharmaceutical industry and advanced healthcare infrastructure. The increasing demand for secure packaging for vaccines, biologics, and medications, particularly after the covid-19 pandemic, has expanded the market. Strong regulatory frameworks and a focus on safety and compliance further boost the market's demand. Additionally, the region's emphasis on sustainable packaging solutions and advancements in eco-friendly materials are shaping the market.
Key players in the market
Some of the key players in Vial Box market include Thermo Fisher Scientific, PPD&G, Merck KGaA, ZEE Packaging, CCL Healthcare, Corning Incorporated, Fuji Seal International, Inc., Becton, Dickinson and Company, Gerresheimer, SGD Pharma, AptarGroup, Schott Pharma, Adelphi Healthcare Packaging, MicroSolv Technology Corporation and DWK Life Sciences.
In February 2024, SGD Pharma introduced a new range of Type I tubular vials featuring Corning's Velocity Vial coating. This innovative coating reduces friction during the fill and finish process, enhancing vial quality and improving manufacturing efficiency. The collaboration between SGD Pharma and Corning aims to optimize global delivery of injectable treatments by minimizing glass particulate emissions and reducing the risk of vial damage.
In January 2024, Schott Pharma has revealed its Everic freeze vials, designed for ultra-cold storage of mRNA and gene therapy drugs. These vials can withstand temperatures as low as -80°C, preventing glass breakage common in standard vials during freezing and thawing. Through scientific testing with eight variants, Schott Pharma found a 0% failure rate for all configurations, showing that CCI can be maintained for all combinations within ISO dimensions.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.